Home Cart Sign in  
Chemical Structure| 3743-23-5 Chemical Structure| 3743-23-5

Structure of 3743-23-5

Chemical Structure| 3743-23-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 3743-23-5 ]

CAS No. :3743-23-5
Formula : C7H7ClO2
M.W : 158.58
SMILES Code : COC1=C(O)C=C(Cl)C=C1
MDL No. :MFCD11100133
InChI Key :HIWHLFQMDDWLRB-UHFFFAOYSA-N
Pubchem ID :588774

Safety of [ 3743-23-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Computational Chemistry of [ 3743-23-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 39.97
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

29.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.04
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.14
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.05
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.75
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.98
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.99

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.55
Solubility 0.448 mg/ml ; 0.00282 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.39
Solubility 0.645 mg/ml ; 0.00407 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.55
Solubility 0.444 mg/ml ; 0.0028 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.75 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.42

Application In Synthesis of [ 3743-23-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3743-23-5 ]
  • Downstream synthetic route of [ 3743-23-5 ]

[ 3743-23-5 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 89694-48-4 ]
  • [ 3743-23-5 ]
YieldReaction ConditionsOperation in experiment
99% With dihydrogen peroxide In ethanol at 80℃; for 0.5 h; Hydrogen peroxide (0.55 ml_, 5.38 mmol) was added to (5-chloro-2- methoxyphenyl)boronic acid (5 g, 26.82 mmol) in EtOH (100 ml_). The resulting solution was stirred at 80 C for 30 minutes, then cooled to room temperature naturally. The solvent was removed under reduced pressure. The residue was dissolved in DCM (200 mL), then washed with saturated brine (100 mL x2), The organic layer was dried over Na2S04, filtered and evaporated to afford 5-chloro-2-methoxyphenol (4.19 g, 99 percent)
95%
Stage #1: at 20℃; for 0.333333 h;
Stage #2: With Oxone; ethylenediaminetetraacetic acid; sodium hydrogencarbonate In acetone at 0 - 20℃; for 24 h;
Stage #3: With hydrogenchloride; sodium sulfite In ethyl acetate; acetone
To a solution of (5-chloro-2-methoxyphenyl)boronic acid (5.Og, 26.82mmol) in water (2OmL) was added sodium hydroxide pellets (1.6g, 40.23mmol) at rt. The reaction mixture was stirred for 20 min and then sodium hydrogen carbonate solution (2OmL) was added, followed by acetone (5OmL) and EDTA (0.8g, 2.68mmol). The mixture was cooled to 0 °C and Oxone.(R). (18.Og, 29.51 mmol) was added. The mixture was warmed to rt over 24h and sodium sulfite (1.2Og) was added followed by concentrated hydrochloric acid (15mL) and EtOAc (3OmL). The phases were separated and the aqueous phase was extracted with EtOAc (3OmL). The organic solutions were combined, dried over magnesium sulfate and the solvent was removed in vacuoto afford the desired compound, 4.Og (95percent). 1H NMR (400 MHz, CDCI3) δ 3.90 (3H, s), 5.60 (1 H, s), 6.80 (1 H, d), 6.90 (1H, d), 6.95 (1 H, s).
References: [1] Patent: WO2018/229083, 2018, A1, . Location in patent: Page/Page column 21-22.
[2] Patent: WO2006/67587, 2006, A2, . Location in patent: Page/Page column 22; 23.
[3] Patent: US6207662, 2001, B1, .
  • 2
  • [ 7035-09-8 ]
  • [ 3743-23-5 ]
References: [1] Journal of Organic Chemistry, 1984, vol. 49, # 6, p. 1051 - 1056.
  • 3
  • [ 507-40-4 ]
  • [ 90-05-1 ]
  • [ 3743-23-5 ]
References: [1] Journal of the American Chemical Society, 1951, vol. 73, p. 2723.
  • 4
  • [ 623-12-1 ]
  • [ 3743-23-5 ]
References: [1] Bulletin des Societes Chimiques Belges, 1985, vol. 94, # 2, p. 115 - 118.
[2] Journal of Organic Chemistry, 2007, vol. 72, # 16, p. 5960 - 5967.
[3] Chemical Communications, 1999, # 22, p. 2259 - 2260.
  • 5
  • [ 58735-58-3 ]
  • [ 3743-23-5 ]
References: [1] Chemical Communications, 2017, vol. 53, # 38, p. 5291 - 5293.
  • 6
  • [ 636-93-1 ]
  • [ 3743-23-5 ]
References: [1] Journal of the Chemical Society, 1955, p. 3681,3683.
  • 7
  • [ 60633-25-2 ]
  • [ 3743-23-5 ]
References: [1] Bulletin de la Societe Chimique de France, 1944, vol. &lt;5&gt; 11, p. 505,509.
  • 8
  • [ 90-05-1 ]
  • [ 3743-23-5 ]
References: [1] Gazzetta Chimica Italiana, 1898, vol. 28 I, p. 226.
  • 9
  • [ 95-03-4 ]
  • [ 3743-23-5 ]
References: [1] Przemysl Chemiczny, vol. 11, p. 369[2] Chemisches Zentralblatt, 1927, vol. 98, # II, p. 809.
  • 10
  • [ 56-23-5 ]
  • [ 507-40-4 ]
  • [ 90-05-1 ]
  • [ 3743-23-5 ]
References: [1] Journal of the American Chemical Society, 1951, vol. 73, p. 2423.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 3743-23-5 ]

Aryls

Chemical Structure| 623-12-1

A160728 [623-12-1]

1-Chloro-4-methoxybenzene

Similarity: 0.89

Chemical Structure| 7051-16-3

A223029 [7051-16-3]

1-Chloro-3,5-dimethoxybenzene

Similarity: 0.88

Chemical Structure| 65262-96-6

A258565 [65262-96-6]

3-Chloro-5-methoxyphenol

Similarity: 0.88

Chemical Structure| 2845-89-8

A112446 [2845-89-8]

1-Chloro-3-methoxybenzene

Similarity: 0.87

Chemical Structure| 18113-03-6

A171762 [18113-03-6]

2-Chloro-4-methoxyphenol

Similarity: 0.85

Chlorides

Chemical Structure| 623-12-1

A160728 [623-12-1]

1-Chloro-4-methoxybenzene

Similarity: 0.89

Chemical Structure| 7051-16-3

A223029 [7051-16-3]

1-Chloro-3,5-dimethoxybenzene

Similarity: 0.88

Chemical Structure| 65262-96-6

A258565 [65262-96-6]

3-Chloro-5-methoxyphenol

Similarity: 0.88

Chemical Structure| 2845-89-8

A112446 [2845-89-8]

1-Chloro-3-methoxybenzene

Similarity: 0.87

Chemical Structure| 18113-03-6

A171762 [18113-03-6]

2-Chloro-4-methoxyphenol

Similarity: 0.85

Ethers

Chemical Structure| 623-12-1

A160728 [623-12-1]

1-Chloro-4-methoxybenzene

Similarity: 0.89

Chemical Structure| 7051-16-3

A223029 [7051-16-3]

1-Chloro-3,5-dimethoxybenzene

Similarity: 0.88

Chemical Structure| 65262-96-6

A258565 [65262-96-6]

3-Chloro-5-methoxyphenol

Similarity: 0.88

Chemical Structure| 2845-89-8

A112446 [2845-89-8]

1-Chloro-3-methoxybenzene

Similarity: 0.87

Chemical Structure| 18113-03-6

A171762 [18113-03-6]

2-Chloro-4-methoxyphenol

Similarity: 0.85